These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29252023)

  • 21. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.
    Serra R; Grande R; Butrico L; Rossi A; Settimio UF; Caroleo B; Amato B; Gallelli L; de Franciscis S
    Expert Rev Anti Infect Ther; 2015 May; 13(5):605-13. PubMed ID: 25746414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common pathogens isolated in diabetic foot infection in Bir Hospital.
    Sharma VK; Khadka PB; Joshi A; Sharma R
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):295-301. PubMed ID: 18603922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriological and therapeutic profile of diabetic foot infection: a prospective study of 100 patients.
    Ben Moussa M; Khalfallah M; Boutiba Ben Boubaker I; Nouira R; Slim A; Jerraya H; Dziri C
    Tunis Med; 2016 Feb; 94(2):95-101. PubMed ID: 27532523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.
    Hartemann-Heurtier A; Robert J; Jacqueminet S; Ha Van G; Golmard JL; Jarlier V; Grimaldi A
    Diabet Med; 2004 Jul; 21(7):710-5. PubMed ID: 15209763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How good are clinicians in predicting the presence of
    Uçkay I; Holy D; Schöni M; Waibel FWA; Trache T; Burkhard J; Böni T; Lipsky BA; Berli MC
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00225. PubMed ID: 33855224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Retrospective Analysis of Microbiologic Profile of Foot Infections in Patients With Diabetic End-Stage Renal Disease.
    Körpinar Ş
    Int J Low Extrem Wounds; 2021 Mar; 20(1):15-21. PubMed ID: 32940096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriology of diabetic foot lesions.
    Yoga R; Khairul A; Sunita K; Suresh C
    Med J Malaysia; 2006 Feb; 61 Suppl A():14-6. PubMed ID: 17042222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypes of isolates of Pseudomonas aeruginosa in a diabetes care center.
    Muthu SE; Aberna RA; Mohan V; Premalatha G; Srinivasan RS; Thyagarajan SP; Rao UA
    Arch Med Res; 2006 Jan; 37(1):95-101. PubMed ID: 16314193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait.
    Al Benwan K; Al Mulla A; Rotimi VO
    J Infect Public Health; 2012 Mar; 5(1):1-8. PubMed ID: 22341838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
    Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
    Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial disease increases the risk of multidrug-resistant bacteria and amputation in diabetic foot infections.
    Aysert Yıldız P; Özdil T; Dizbay M; Güzel Tunçcan Ö; Hızel K
    Turk J Med Sci; 2018 Aug; 48(4):845-850. PubMed ID: 30119162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of yeasts in diabetic foot ulcer infection].
    Missoni EM; Kalenić S; Vukelić M; De Syo D; Belicza M; Kern J; Babić VV
    Acta Med Croatica; 2006; 60(1):43-50. PubMed ID: 16802571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the scientific evidence for biofilms in wounds.
    Percival SL; Hill KE; Williams DW; Hooper SJ; Thomas DW; Costerton JW
    Wound Repair Regen; 2012; 20(5):647-57. PubMed ID: 22985037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Assessment of Intralesional Epidermal Growth Factor for Treating Diabetic Foot Wounds
    Ertugrul BM; Lipsky BA; Guvenc U;
    J Am Podiatr Med Assoc; 2017 Jan; 107(1):17-29. PubMed ID: 28271944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study.
    Nassaji M; Ghorbani R; Saboori Shkofte H
    Wounds; 2017 Jul; 29(7):196-201. PubMed ID: 28762948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of bacteria in diabetic and non-diabetic foot infection - An investigation in patients from Bangladesh.
    Karmaker M; Sanyal SK; Sultana M; Hossain MA
    J Infect Public Health; 2016; 9(3):267-77. PubMed ID: 26617249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
    El-Naggar MY; Gohar YM; Sorour MA; Waheeb MG
    J Microbiol Biotechnol; 2016 Feb; 26(2):408-20. PubMed ID: 26597531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor vs platelet-rich plasma: Activity against chronic wound microbiota.
    de Oliveira BGRB; de Oliveira FP; Teixeira LA; de Paula GR; de Oliveira BC; Pires BMFB
    Int Wound J; 2019 Dec; 16(6):1408-1415. PubMed ID: 31571388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.
    Seth AK; Zhong A; Nguyen KT; Hong SJ; Leung KP; Galiano RD; Mustoe TA
    Wound Repair Regen; 2014; 22(6):712-9. PubMed ID: 25230854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.